Basic Information
Basic information for LINC00839-202-141aa
Peptide Name LINC00839-202-141aa
Genome Position chr10:42475714-42475880,42477261-42477442,42486979-42487052[+]
Species Human
Peptide Sequence MLEAGGSEAATARGRGDFGAASCSDLAFRCASSQNPRSLEPVASSPERRRRQPSRAFACTLPGCWRLEAVTQQQREATLERPHIATSPSAARPPRAQEARNLWHPSLKGEDGNPAEALLGWGLHDRAGLIKWRPTRGSNPG
Peptide Length 141
Unique No (LINC00839-203-141aa,LINC00839-204-141aa)
Grand Average of Hydropathicity -0.7482
Relative Molecular Mass 17744.14
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000185904;LINC00839
Transcript ID/Name ENST00000429940;LINC00839-202
Transcript Length 2254
Coding Ability 0.3957
DNA Sequence Corresponding to Peptide ATGCTGGAGGCTGGAGGCAGTGAGGCAGCAACAGCGCGAGGGCGAGGCGACTTTGGAGCTGCCTCATGCAGCGACCTCGCCTTCCGCTGCGCCTCCTCCCAGAACCCAAGAAGCCTGGAACCTGTGGCGTCCAGCCCTGAAAGGAGGAGACGGCAACCCAGCCGCGCTTTTGCCTGCACTCTCCCTGGATGCTGGAGGCTGGAGGCAGTGACGCAGCAACAGCGCGAGGCGACTTTGGAGCGGCCTCATATAGCGACCTCGCCTTCCGCTGCGCGTCCTCCCAGAGCCCAAGAAGCCCGGAACCTGTGGCATCCATCTCTGAAAGGAGAAGACGGCAACCCAGCCGAGGCACTACTGGGTTGGGGTCTCCACGACCGAGCTGGTCTCATCAAGTGGCGTCCAACAAGGGGCTCAAACCCGGGT
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :